Geron Corp (GERN) option IV into FDA Oncologic Drugs Advisory Committee meeting

Geron Corp (NASDAQ: GERN) 30-day option implied volatility is at 265; compared to its 52-week range of 56 to 220 into FDA Oncologic Drugs Advisory Committee meeting.

You May Also Be Interested In

• Alphabet (GOOGL) call put ratio 1.6 calls to 1 put with a focus on June 22 weekly calls as share price down 6%
• Vail Resorts (MTN) call put ratio 1 call to 1 put amid price movement
• Sandisk (SNDK) call put ratio 1 call to 1.3 puts a focus on June 26 weekly puts as share price up 6%